SOURCE: Varian Semiconductor

March 05, 2007 10:15 ET

Varian Semiconductor's Bob Halliday Named Among America's Top CFOs by Institutional Investor Magazine

GLOUCESTER, MA -- (MARKET WIRE) -- March 5, 2007 -- Varian Semiconductor Equipment Associates, Inc. (NASDAQ: VSEA) today announced that Bob Halliday, the company's Executive Vice President and CFO, has been named the top ranked CFO in the Semiconductor Capital Equipment industry and a top CFO nationally by Institutional Investor magazine.

For Institutional Investor's fourth annual ranking, Halliday was one of 60 financial chiefs across the country who scored the highest when portfolio managers and analysts were asked to identify the top-performing CFOs in America. Halliday was featured, along with other winning CFOs, in Institutional Investor magazine's February 2007 issue.

Institutional Investor polled portfolio managers and analysts at more than 400 of the world's biggest and most influential money management houses, retirement systems, foundations and endowments to find out who they considered the best financial executives in the country. Nearly 800 responded, representing $6.3 trillion in U.S. equity assets under management.

According to the magazine's article, "These asset managers were asked a simple question: Who is the best CFO in the sector (or sectors) for which you are responsible. The respondents gave their first, second and third choices, which were weighted to produce a score for each CFO."

Financially, Varian Semiconductor's market share gains drove the Company to 2006 records in sales, earnings and cash generation. Varian Semiconductor is the world's leader in ion implant market share -- more than twice that of its nearest competitor. The Company's superior products have resulted in, and should continue to result in, unprecedented market share gains.

About Varian Semiconductor

Varian Semiconductor Equipment Associates is the leading supplier of ion implant equipment to semiconductor manufacturers, enabling them to pack more, higher performing transistors into computer chips that are revolutionizing the electronics industry. Varian Semiconductor's products are used by chip manufacturers worldwide to produce high-performance semiconductor devices. Customers have made Varian Semiconductor the market leader in ion implant because of its architecturally superior products that lower their costs and improve their productivity. The Company has ranked #1 in the VLSI Research Customer Satisfaction Survey nine times over the last ten years. Varian Semiconductor operates globally and is headquartered in Gloucester, Massachusetts. More information can be found on Varian Semiconductor's web site at

About Institutional Investor

Institutional Investor magazine has been the flagship publication of II for nearly 40 years and has continuously provided ground-breaking detailed coverage of the events, issues and people who impact the world of business and finance. With industry recognized research and ratings, award-winning editorial and exclusive interviews, Institutional Investor magazine is the publication more C-level executives turn to for industry trends and analysis.

Note: This release contains forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. For this purpose, the statements concerning the Company's performance, market share and technology leadership, technological capabilities and benefits and growth are forward-looking statements and any statements using the terms "believes," "anticipates," "expects," "plans," or similar expressions are forward-looking statements. There are a number of important risks and factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These include, among others, volatility in the semiconductor equipment industry; economic conditions in general and as they affect the Company's customers; significant fluctuations in the Company's quarterly operating results; the impact of rapid technological change; the Company's dependence on the development and introduction of new products; the Company's concentration on ion implantation systems and related products; concentration in the Company's customer base and lengthy sales cycles; the highly competitive market in which the Company competes; the risks associated with international sales; foreign currency risks; and general economic conditions; and other factors identified in the Company's Annual Report on Form 10-K, and the most recent Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission. The Company cannot guarantee any future results, levels of activity, performance or achievement. The Company undertakes no obligation to update any of the forward-looking statements after the date of this press release.

Contact Information

  • Contacts:
    Jim Monahan
    Manager, Marketing Communications
    Mary Wright
    Director, Investor Relations